Influence of Hepatocyte-Rich Liver Cell Mixture and Liver Fibroblasts on Prolonging Graft Islet Survival in Rats without Immunosuppressive Drugs

 

 Buy Article Permissions and Reprints

Abstract

Background: We noted that a liver cell suspension, made up of a mixture of several kinds of hepatic cells, affected allogenic islet survival when it was transplanted into the liver, mixed with the islets or separately.

Aim: To study if this effect was related to a liver cell mixture rich in hepatocytes (hp) or to liver fibroblasts (fb).

Methods: We studied 14 groups of rats: (A) a sham group with saline; (B) a group receiving transplantation with hepatic cells alone; (C) a control group, with islets alone via the portal vein, without hepatic cells (hp or fb). For the other groups, we used a different ratio of cells/islets (100 : 1, 150 : 1 and 200 : 1) and different co-transplantation techniques with both types of cells. For the D, E, J groups, a mixture of hepatocytes (hepatocyte-rich liver cell mixture) or fibroblasts with islets was injected into the portal vein. For the other groups, we used a sequential procedure with a 15 minute interval between a first injection of hp or fb into the portal vein or into the vena cava, and a second injection of islets always into the portal vein; thus, it was a sequential portal/portal procedure with hepatocyte-rich liver cell mixture (hp) (F, G) or fibroblasts (K, L) and a sequential cava/portal with hp (H, I) or fibroblasts (M, N).

Results: Most of the co-transplantation groups showed functional islets (blood glucose < 250 mg/dl) on the first or second day of transplantation; after several days they once again had high glucose levels, though not as high as pre-transplantation. There was statistical significance (p < 0.001) between the presence or not of hepatic cells to obtain prolongation of graft survival (blood glucose < 250 mg/dl). Statistical significance (p < 0.001) was found for several sequential groups with hp (F, I) and fb (K, L). It was also remarkable that 3 rats (37.5 %) from the I group (sequential cava/portal with hp/islets 200 : 1) were euglycemic (blood glucose < 150 mg/dl) for more than 3 months. ANOVA showed a large interaction between the type of transplant performed and the cellular ratio used, with a significance of p < 0.001. Histological studies in rats with prolonged euglycemia, showed insulin-producing cell aggregates in the liver, while there was a remarkable decrease in insulin-producing cells in the remaining islets of pancreatic tissue.

Conclusion: The results showed a marginal prolongation of islet graft survival when they are co-transplanted with a hepatocyte-rich liver cell mixture or with liver fibroblasts. The mechanism does not seem to be a cellular interaction between different hepatic cells and islets, but some kind of cellular interaction or released factor from either two cell types on the immune system, blocking or modulating it, at least temporarily.

References

• 1 Alvarez S, Soto M L, Martínez B, Arranz A, Martín M C, Jara A. Diabetes reversion after allotransplantation of islets previous cultured in RPMI for 7 - 8 days compared with 1 - 2 days.  Endocrinologia. 1997;  44 119-121
  PubMedGoogle Scholar
• 2 Chiang Y J, Lu L, Fung J J, Qian S. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of a sponge implant as a cell transplant model.  Cell Transplant. 2001;  10 343-350
  PubMedGoogle Scholar
• 3 Dafoe D C, Wang X, Tafra L, Berezniak R, Lloyd R V. Studies of composite grafts of fetal pancreas (FP) and fetal liver (FL) in the streptozotocin-induced diabetic rat.  Adv Exp Med Biol. 1992;  321 171-177
  PubMedGoogle Scholar
• 4 Del Río R, Soto M L, Alvarez S, Martínez B, Arranz A, Martin-Scapa M C, Jara A. Study of the number and purity of pancreatic rat islet cells in vivo and in vitro in more than 500 isolations.  Avances en Diabetología. 1997;  13 139-143
  PubMedGoogle Scholar
• 5 Ikebukuro K, Adachi Y, Yamada Y, Fujimoto S, Seino Y, Oyaizu H, Hioki K, Ikehara S. Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats.  Transplantation. 2002;  73 512-518
  PubMedGoogle Scholar
• 6 Jara-Albarrán A, Soto-Montenegro L, del Rio R, Alvarez S, Martin-Scapa C. Influence of hepatic cells on allogeneic islet transplantation in rats without immunosuppressive drugs.  Horm Metab Res. 2001;  33 30-33
  Article in Thieme ConnectPubMedGoogle Scholar
• 7 Jara A, Soto M L, Del Río R, Zugasti A, Malvetti V. Induction of tolerance to pancreatic islet transplantation with different hepatic cell subpopulations. without immunosuppressive drugs.  Acta Chirurgica Austriaca. 2001;  33 (Suppl) 70
  PubMedGoogle Scholar
• 8 Jara-Albarrán A, Soto-Montenegro M L, Zugasti A, Rollán E, Alvarez Y, Alvarez G. Hepatic cells via cava vein can influence allogenic islet rat transplantation.  Cell Transplant. 2003;  12 891-896
  PubMedGoogle Scholar
• 9 Kaufmann P M, Fiegel H C, Kneser U, Pollok J M, Kluth D, Rogiers X. Influence of pancreatic islets on growth and differentiation on hepatocytes in co-culture.  Tissue Eng. 1999;  5 583-596
  PubMedGoogle Scholar
• 10 Kang S M, Braat D, Schneider D B, O'Rourke R W, Lin Z, Ascher N L, Dichet D A, Baekkeskov S, Stock P G. A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants.  Transplantation. 2000;  69 1813-1817
  PubMedGoogle Scholar
• 11 Korbutt G S, Elliott J F, Rajotte R V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression.  Diabetes. 1997;  46 317-322
  PubMedGoogle Scholar
• 12 Lake S P, Anderson J, Chamberlain J, Gardner S J, Bell P R, James R F. Bovine serum albumin density gradient isolation of rat pancreatic islets.  Transplantation. 1987;  43 805-808
  PubMedGoogle Scholar
• 13 Latif Z A, Noel J, Alejandro R. A simple method of staining fresh and cultured islets.  Transplantation. 1988;  45 827-830
  PubMedGoogle Scholar
• 14 Lau H T, Yu M, Fontana A, Stoeckert Jr C J. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.  Science. 1996;  273 109-112
  PubMedGoogle Scholar
• 15 Legrelle M, Chapa O, Race J M, Mallegol S, Capron F, Altman J J. Islet and hepatocyte cotransplantation in rats.  Transplant Proc. 1993;  25 981
  PubMedGoogle Scholar
• 16 Markees T G, Appel M C, Noelle R J, Mordes J P, Greiner D L, Rossini A A. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.  Transplant Proc. 1996;  28 814-815
  PubMedGoogle Scholar
• 17 Ricordi C, Flye M W, Lacy P E. Renal subcapsular transplantation of clusters of hepatocytes in conjunction with pancreatic islets.  Transplantation. 1988;  45 1148-1151
  PubMedGoogle Scholar
• 18 Ricordi C, Hering B J, London N JM, Rajotte R V, Gray D WR, Sutherland D ER. Islet isolation assessment. Ricordi C Pancreatic Islet Cell Transplantation. Austin, TX; Landes Co. 1992: 132-142
  Google Scholar
• 19 Ricordi C, Murase N, Rastellini C, Behboo R, Demetris A J, Starzl T E. Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation.  Cell Transplant. 1996;  5 53-55
  PubMedGoogle Scholar
• 20 Sandbichler P, Erhart R, Herbst P, Schmid T, Vogel W, Thaler W, Totsch M, Klima G, Margreiter R. Simultaneous transplantation of isolated hepatocytes reduces rejection of small bowel allografts and improves survival in the rat.  Eur Surg Res. 1996;  28 222-226
  PubMedGoogle Scholar
• 21 Sawada T, Asanuma Y, Furuya T, Saito K, Koyama K. Tolerance of islet allografts induced by orthotopic liver transplantation.  Surg Res. 1999;  85 209-216
  PubMedGoogle Scholar
• 22 Seglen P O. Preparation of isolated rat liver cells.  Methods Cell Biol. 1976;  13 29-83
  PubMedGoogle Scholar
• 23 Selawry H, Fojaco R, Whittington K. Extended survival of MHC-compatible islet grafts from diabetes-resistant donors in spontaneously diabetic BB/W rat.  Diabetes. 1987;  36 1061-1067
  PubMedGoogle Scholar
• 24 Selawry H P, Cameron D F. Sertoli cell-enriched fractions in successful islet cell transplantation.  Cell Transplant. 1993;  2 123-129
  PubMedGoogle Scholar
• 25 Sun J, Wang X, Wang C, Sheil A G. Sequential transplantation induces islet allograft tolerance.  Microsurgery. 2001;  21 148-152
  CrossrefPubMedGoogle Scholar
• 26 Tafra L, Berezniak R, Dafoe D C. Beneficial effects of fetal liver tissue on pancreatic transplantation.  Surgery. 1990;  108 734-740
  PubMedGoogle Scholar
• 27 Takeda Y, Gotoh M, Dono K, Nishihara M, Grochowiecki T, Kimura F, Yoshida T, Ohta Y, Ota H, Ohzato H, Umeshita K, Takeda T, Matsuura N, Sakon M, Kayagaki N, Yagita H, Okumura K, Miyasaka M, Monden M. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.  Diabetologia. 1998;  41 315-321
  CrossrefPubMedGoogle Scholar
• 28 Wang C, Sun J, Li L, Wang L, Dolan P, Sheil A G. Conversion of pancreas allograft rejection to acceptance by liver transplantation.  Transplantation. 1998;  65 188-192
  PubMedGoogle Scholar
• 29 Wang X Y, Sun J, Wang C, France M, Sheil A G. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.  Transplantation. 2001;  71 102-111
  PubMedGoogle Scholar
• 30 Yang L, Li S, Hatch H, Ahrens K, Cornelius J G, Petersen B E, Peck A B. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells.  Proc Natl Acad Sci USA. 2002;  99 8078-8083
  CrossrefPubMedGoogle Scholar
• 31 Yoo-Ott K A, Schiller H, Fandrich F, Oswald H, Richter K, Xhu X F, Kampen W U, Kronke M, Zavazava N. Co-transplantation of donor-derived hepatocytes induces long-term tolerance to cardiac allografts in a rat model.  Transplantation. 2000;  69 2538-2546
  PubMedGoogle Scholar

Prof. A. Jara Albarrán

Department of Endocrinology
Hospital General Universitario Gregorio Marañón

C/Doctor Esquerdo 46

28007-Madrid

Spain

Phone: + 34915868112

Fax: + 34 9 15 86 81 13

Email: ajara@radonc.hggm.es